Funding

This prospective, randomized pilot study compares the use of a xenograft with PRP to a xenograft alone for chronic, nonhealing wounds.

Inclusion Criteria:

• Patient is over the age of 18 years;
• The targeted wound is deemed a chronic, nonhealing wound after six weeks of treatment; - - Patient of Dr. Eldridge, Dr. Glenn, or Dr. Worley;
• Target wound size must be between 2 cm x 2 cm x 0.1 cm deep and 10 cm x 10 cm x 5 cm deep;
• Surgical candidate for standard of care Kerecis® xenograft surgery.

Exclusion Criteria:

• Patient with hemoglobin values less than 6.9 g/dL drawn at least 30 days prior to the Kerecis® xenograft surgery;
• Patient with a known allergy or other sensitivity to fish material;
• Patient is currently undergoing chemotherapy or radiation therapy;
• The targeted wound is of autoimmune origin; and Non-English-speaking patients.